A differential diagnosis of a head and neck bony lesion: Review of a case series with 18 patients with extraintestinal features of familial adenomatous polyposis 1 
| INTRODUCTION
We would like to draw to the attention of head and neck surgeons the following disease that can present first to head and neck specialists with either a head and neck lump or following an incidental finding on radiological imaging.
Familial adenomatous polyposis (FAP) is a hereditary disease
caused by a mutation in the APC gene on chromosome 5, which is inherited in an autosomal dominant fashion with complete penetrance but variable expression. 1 However in approximately 25% of cases, it arises from a de novo mutation of the APC gene. 1 FAP affects between 1 in 13 000 and 18 000 live births in the Northern European population 2 and is characterised by hundreds to thousands of colorectal polyps, which almost inevitably lead to colorectal cancer (CRC) by the age of 35-40 years without a prophylactic proctocolectomy. 2, 3 In the Swedish Famil- Osteoma was found in 18 patients, which is 4.3% of patients in the FAP registry. These patients are described in Table 1 . In six (33%) of these 18 patients, an osteoma was the first presentation of the disease to a healthcare professional, and they were subsequently diagnosed with FAP. Ten (55%) had multiple osteomas at presentation, and 8 (45%) had a solitary osteoma at presentation.
| DISCUSSION
This was a review of the registry based on the diagnoses available.
These FAP patients were not routinely screened radiologically for osteomas; therefore, these findings and diagnoses have been incidental. The patients who were found to have osteomas were of a similar gender distribution to the general FAP population. Patients who presented first with osteomas were diagnosed at a median age of 20 years. Interestingly, there was no significant difference between the ages at diagnosis in the patients who presented first with the osteoma compared to the group with osteomas present.
Keypoints
• Familial adenomatous polyposis (FAP) is an autosomal dominant cancer syndrome.
• FAP can affect most body systems, and patients can develop osteomas and tumours of the skin, which can be detected before the onset on cancer.
• We present 18 patients from a register of 419 patients with FAP who reportedly had an osteoma. Two thirds (94%) of these patients had osteomas in the mandible or maxilla.
• One-third of the patients with osteomas presented first with the osteomas and were subsequently diagnosed with FAP.
• The presence of osteomas can predate the development of symptoms in FAP by many years. In these cases, the diagnosis of FAP would have been possible much earlier if the clinicians were aware of FAP syndrome; however due to the limited sample size, it is difficult to infer whether this is representative.
T A B L E 1 Patient demographics and osteoma location
In our sample, the most common site of osteomas was in the mandible, in keeping with the literature where the angle of the mandible is the most common location. ; there is sign of growth in osteomas situated within the sinuses; their location risks obstruction of anatomical drainage sites; they cause symptoms of chronic sinusitis; they risk impinging on important structures such as the orbit. 9 The imaging modality of choice is thin-slice CT to allow a precise estimation of size and location of the osteoma. 8, 10 From our retrospective case series, we are aware of two of the patients having had surgical treatment for their osteomas. One had a wide frontal bone excision with bony reconstruction using the iliac crest, and the other had the osteoma excised.
Although this is a rare diagnosis, FAP has serious clinical significance especially if missed, as without prophylactic colectomy/proctocolectomy the risk of colorectal cancer is almost inevitable. It is important to ask about osteomas or lumps elsewhere, family history of gastrointestinal pathology, cancers and gastrointestinal symptoms, and to refer to a unit with expertise in the field of this hereditary polyposis if there is any suggestion that this could be FAP. Important symptoms to ask about are weight loss, diarrhoea, mucous discharge, rectal bleeding, abdominal pain or cramping, and anaemia status should also be assessed. 8 It is advised that patients with FAP undergo bowel, upper gastrointestinal, thyroid and possibly hepatic surveillance given the associated malignancy risk.
2,4,8
Lack of screening for osteomas, thus it is difficult to know the accurate incidence and locations in this population.
2. Historical nature of the notes. Usually, osteomas were incidental, and little information was written about them.
3. Small sample size.
| CONCLUSION
We want to raise awareness of the presence osteomas and their role in FAP, which is a significant life-limiting disease, so that the patient and family can be screened for this and managed accordingly.
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There are no conflict of interests. and was cost-effective. 2 However, the addition of concurrent chemotherapy to radiotherapy is often contraindicated due to comorbidity and has not been found to be beneficial to patients with stage I/II disease, age ≥70 years old, WHO performance status ≥2. 4 There is a paucity of data to determine whether response assessment PET-CT after radiotherapy alone is sufficiently accurate to influence management.
In our centre, we have adopted a policy of observation if a complete metabolic response on PET-CT is achieved following radiotherapy AE chemotherapy. 3, 5 The aim of this report was to analyse the accuracy of FDG PET-CT response assessment following radiotherapy alone without a planned neck dissection.
| METHODS
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